{
    "organizations": [],
    "uuid": "568a1452fc86cc370f6be00742f958a06eca621e",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-xenon-pharma-teva-pharma-terminate/brief-xenon-pharma-teva-pharma-terminate-development-license-agreement-idUSASB0C99D",
    "ord_in_thread": 0,
    "title": "BRIEF-Xenon Pharma, Teva Pharma Terminate Development & License Agreement",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 7 (Reuters) - Xenon Pharmaceuticals Inc:\n* XENON PHARMACEUTICALS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE\n* XENON PHARMA - CO, TEVA PHARMACEUTICALS INTERNATIONAL GMBH, TEVA CANADA, ENTERED DEAL TO MUTUALLY TERMINATE DEC 7, 2012 DEVELOPMENT & LICENSE AGREEMENT\n* XENON PHARMA - AS PER TERMINATION AGREEMENT, TEVA AGREED TO TRANSFER AND ASSIGN 1 MILLION SHARES OF CO HELD BY TEVA CANADA LTD TO CO FOR CANCELLATION Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-08T05:40:00.000+02:00",
    "crawled": "2018-03-08T17:01:51.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "xenon",
        "pharmaceutical",
        "inc",
        "xenon",
        "pharmaceutical",
        "report",
        "financial",
        "result",
        "provides",
        "corporate",
        "update",
        "xenon",
        "pharma",
        "co",
        "teva",
        "pharmaceutical",
        "international",
        "gmbh",
        "teva",
        "canada",
        "entered",
        "deal",
        "mutually",
        "terminate",
        "dec",
        "development",
        "license",
        "agreement",
        "xenon",
        "pharma",
        "per",
        "termination",
        "agreement",
        "teva",
        "agreed",
        "transfer",
        "assign",
        "million",
        "share",
        "co",
        "held",
        "teva",
        "canada",
        "ltd",
        "co",
        "cancellation",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}